Skip to main content

Jeff Lagasse

By Jeff Lagasse | 11:16 am | April 03, 2024
Total gross Medicare spending on GLP-1 drugs has skyrocketed, rising from $57 million in 2018 to $5.7 billion in 2022.
By Jeff Lagasse | 07:27 pm | April 02, 2024
Rex replaces outgoing president Dirk McMahon and will continue his CFO duties in his new role.
By Jeff Lagasse | 10:33 am | April 02, 2024
The agency stresses the importance of obtaining and documenting informed consent before performing sensitive examinations.
By Jeff Lagasse | 08:44 pm | April 01, 2024
The additional capital will help Pelago accelerate its product roadmap and advance clinical research efforts.
By Jeff Lagasse | 10:53 am | April 01, 2024
Four are being sold to UCI Health for about $975 million, while two have been sold to Adventist Health for an undisclosed amount.
By Jeff Lagasse | 09:43 am | April 01, 2024
The draft outlines federal health IT goals that are focused on improving access to health data.
By Jeff Lagasse | 10:47 am | March 29, 2024
If finalized, total payments are estimated to increase by $70 million in 2025.
By Jeff Lagasse | 06:38 pm | March 28, 2024
This is despite payment errors under Medicaid dropping by $30 billion from the previous year.
By Jeff Lagasse | 10:39 am | March 28, 2024
Habitat Health is designed to help participants live independently in their homes, beginning first in California and then nationally.
By Jeff Lagasse | 08:50 am | March 28, 2024
The American Hospital Association took issue with the report, saying the methodology is flawed.